欧洲胰腺癌研究组（ESPAC）-3研究在欧洲、澳大利亚、日本及加拿大癌症中心的159名患者中进行。
The European Study Group for Pancreatic Cancer (ESPAC)-3 trial was conducted in 159 pancreatic cancer centers in Europe, Australasia, Japan, and Canada.
欧洲胰腺癌研究组（ESPAC）-3研究在欧洲、澳大利亚、日本及加拿大癌症中心的159名患者中进行。
The European Study Group for Pancreatic Cancer (ESPAC)-3 trial was conducted in 159 pancreatic cancer centers in Europe, Australasia, Japan, and Canada.
应用推荐